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DegradationThe connexins constitute a family of integral membrane proteins that form intercellular channels, enabling
adjacent cells in solid tissues to directly exchange ions and small molecules. These channels assemble into
distinct plasma membrane domains known as gap junctions. Gap junction intercellular communication
plays critical roles in numerous cellular processes, including control of cell growth and differentiation, main-
tenance of tissue homeostasis and embryonic development. Gap junctions are dynamic plasma membrane
domains, and there is increasing evidence that modulation of endocytosis and post-endocytic trafﬁcking of
connexins are important mechanisms for regulating the level of functional gap junctions at the plasma mem-
brane. The emerging picture is that multiple pathways exist for endocytosis and sorting of connexins to
lysosomes, and that these pathways are differentially regulated in response to physiological and pathophysio-
logical stimuli. Recent studies suggest that endocytosis and lysosomal degradation of connexins is controlled
by a complex interplay between phosphorylation and ubiquitination. This review summarizes recent progress
in understanding the molecular mechanisms involved in endocytosis and post-endocytic sorting of connexins,
and the relevance of these processes to the regulation of gap junction intercellular communication under normal
and pathophysiological conditions. This article is part of a Special Issue entitled: The Communicating junctions,
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Connexins are tetramembrane spanning proteins that are able to
form channels between adjacent cells. These channels assemble into
intercellular plasma membrane domains known as gap junctions
[1]. The connexin gene family constitutes 20 members in humans
[2,3]. Connexins are expressed in nearly all cell types, both during de-
velopment and in the adult organism [4]. Most tissue types express
several connexin isoforms. Gap junctions enable adjacent cells in
solid tissues to directly exchange ions, such as K+ and Ca2+, second
messengers, such as inositol triphosphate, ATP, cAMP, and cGMP,
and small metabolites, including glucose and glutamate. Gap junc-
tions have a fundamental role in tissues containing electrically excit-
able cells. For instance, gap junctions function as electrical synapses
between neurons and have important roles in the synchronous con-
traction of the heart muscle by mediating electrical coupling between
cardiomyocytes [5,6]. Gap junctions also have critical roles in non-
excitable tissues, by regulating cell growth and differentiation,
embryonic development and tissue homeostasis [7,8]. Loss of function-
al gap junction channels has been implicated as a causative factor in
multiple diseases, including heart failure, neuropathology, deafness,
skin disorders and cataracts [9]. There is also substantial evidence that
loss of connexin expression is important in cancer development, and
several members of the connexin gene family act as tumor suppressors
[10,11].
Intercellular communication via gap junctions is controlled by
multiple mechanisms. The most rapid regulation of gap junction
channels is achieved by altering the conductance of single channels
or their probability of opening [12]. Slower regulation of gap junc-
tions can be achieved by changing the rate of connexin synthesis, traf-
ﬁcking of connexins to the plasma membrane or assembly of
connexins into gap junctions [12]. There is also increasing evidence
that modulation of connexin endocytosis and sorting to lysosomes
may be critically involved in controlling gap junction intercellular
communication [13–16]. Here, we review recent progress in under-
standing the mechanisms involved in the regulation of connexin
endocytosis and post-endocytic sorting to lysosomes. We also discuss
how modulation of the connexin endocytosis and degradation rates
might play important roles in controlling the level of functional gap
junctions under normal and pathological conditions.
2. Synthesis and trafﬁcking of connexins to the plasma membrane
Connexin proteins span the membrane four times and have their
amino and carboxy termini localized on the cytosolic side of the
membrane [4]. The four transmembrane regions, the two extracellu-
lar loops and the amino terminus contain several identical residues
among the various connexins. In contrast, the length and amino acid
compositions of the carboxyl terminus and the intracellular loop
vary extensively between connexins. Connexin proteins are most
commonly referred to by their predictedmolecular weight in kilodaltons.
The best-studied connexin isoform is connexin 43 (Cx43).
Connexins are generally considered to be co-translationally
inserted into the endoplasmic reticulum, although cell-free studies
indicate that Cx26 can also insert into membranes post-translationally
or directly into the plasma membrane [17–19]. Connexins with correct
conformation are transported via the Golgi apparatus and the trans-
Golgi network to the plasma membrane [20–23]. Cx26 may also follow
an alternative route to the plasmamembrane that bypasses the conven-
tional secretory pathway [24–26]. Along their trafﬁcking from the endo-
plasmic reticulum to the plasmamembrane, connexins oligomerize into
hexameric structures that form a cylinderwith an aqueous pore extend-
ing through the channel, called a connexon. Connexons can consist of
six identical or different connexin isotypes, termed homomeric and
heteromeric connexons, respectively [4]. In contrast to the oligomeriza-
tion of most other multisubunit integral membrane proteins, Cx43 andCx46 oligomerize after they have left the endoplasmic reticulum, prob-
ably in the trans-Golgi network [20,27,28]. On the other hand, Cx32
oligomerizes within the endoplasmic reticulum, suggesting that the
site of oligomerization is isoform speciﬁc [29,30]. The trafﬁcking of
connexons from the trans-Golgi network to the plasma membrane is
mediated by microtubules [31–34]. A recent study by del Castillo et al.
shows that transport of connexons from the trans-Golgi network to
the plasma membrane is regulated by the integral membrane protein
consortin [35].
At least 40% of newly synthesized wild-type Cx43 and Cx32 and up
to 100% of some mutant forms of Cx32 have been estimated to under-
go endoplasmic reticulum-associated degradation (ERAD) [36,37].
Although Cx32 and Cx43 are the only connexin isoforms known to
undergo ERAD, it is anticipated that ERAD is a general mechanism
underlying quality control of connexins. The degradation of Cx32
and Cx43 at the endoplasmic reticulum is strongly affected by various
cytosolic stressors [37]. Oxidative or thermal stress inhibits disloca-
tion to the cytosol and subsequent proteasomal degradation of Cx32
and Cx43 [37]. The wild-type connexin protein escaping ERAD in
response to cytosolic stress remains in a full-length, membrane-
integrated form, and is able to undergo trafﬁcking via the secretory
pathway and form functional gap junctions at the plasma membrane
[37]. Reducing connexin ERAD has been hypothesized to be a mecha-
nism for upregulating gap junctional communication under normal
physiological conditions and under pathological conditions, such as
ischemia-reperfusion injury and fever [38]. In line with the notion
that controlled ERAD of connexins may have important physiological
roles, androgen depletion has been shown to induce degradation of a
major fraction of Cx32 and Cx43 at the endoplasmic reticulum in
human prostate cancer cells [39]. The enhanced degradation of con-
nexins in response to androgen depletion is associated with reduced
gap junctional intercellular communication. The degradation of
Cx43 at the endoplasmic reticulum is regulated in part by CIP75 (con-
nexin43-interacting protein of 75-kDa) [40]. CIP75 belongs to the UbL
(ubiquitin-like)-UBA (ubiquitin-associated) protein family, which is
involved in the translocation of proteins across the endoplasmic retic-
ulum membrane, and in mediating the delivery of proteins to protea-
somes during ERAD [41]. Recently, Su et al. found that CIP75
stimulates proteasomal degradation of Cx43 at the endoplasmic retic-
ulum in a process independent of Cx43 ubiquitination [42].
3. Assembly of connexons into gap junctions
Connexons are delivered to the plasma membrane at non-gap
junctional sites, and diffuse laterally to the periphery of the gap junc-
tion plaques where they dock with connexons in neighboring cells to
form intercellular channels [23,33]. Docking between connexons
occurs by a “lock and key” mechanism involving six protrusions
from each connexon [4,43,44]. By electron microscopy, gap junctions
can be identiﬁed as intercellular areas in which the two plasma mem-
brane domains are tightly apposed to each other. The twomembranes
of a gap junction appear to be separated by an extracellular gap of 2–
4 nm for which the junction is named [45,46]. The conductance and
selectivity of a gap junction channel is strongly affected by its con-
nexin composition. Connexons in one cell can dock with connexons
consisting of different connexin isoforms in the adjacent cell to form
a so-called heterotypic gap junction channel [1]. The connexin com-
position of the gap junction channels differs signiﬁcantly between
cell and tissue types. Different combinations of connexin isoforms
enable the various cell types to form gap junctions with different con-
ductive and selective properties. Moreover, expressing several con-
nexin isoforms might have a compensating role, enabling cells to
express functional gap junctions even if one of the isoforms is mutated
or lost. Although the best-known function of connexins is to form gap
junction channels, substantial evidence indicates that connexons at
the plasma membrane that are not assembled in gap junctions may
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molecules between the extracellular and intracellular environments,
and are often referred to as hemichannels [47]. Under normal condi-
tions, most hemichannels are considered to be in a closed state, but
stimuli such as mechanical stress or reduced calcium concentration in
the extracellular space can provoke channel opening [48–53].
The formation of gap junctions is intimately linked to the forma-
tion of adherens junctions. Several studies indicate that assembly of
connexons into gap junction plaques is facilitated by adherens junc-
tion formation [54–59]. It has been suggested that the close mem-
brane–membrane contact formed by adherens junctions facilitates
the assembly of connexons into gap junctions. There is also increasing
evidence that assembly of gap junctions and adherens junctions in-
volves a reciprocal relationship between the two junction complexes.
For instance, Lo and co-workers have found that Cx43 and N-cadherin
may co-assemble in a multiprotein complex, and that expression of
Cx43 at the cell surface is dependent on N-cadherin and, vice versa,
that N-cadherin expression at the cell surface requires Cx43 [59].
The role of E-cadherin and N-cadherin in gap junction assembly is
likely to differ between different cell types. Recently, Mehta and
colleagues reported that E-cadherin and N-cadherin may have oppo-
site effects on the assembly of Cx43 into gap junction plaques in rat
liver epithelial cells [56]. While E-cadherin was found to facilitate
assembly of Cx43 into gap junctions, N-cadherin attenuated the
assembly by causing endocytosis of Cx43.
The rate of aggregation of undocked Cx43 connexons into gap
junctions is regulated by the scaffold protein ZO-1 (zonula occludens-
1). ZO-1 interacts directly with various connexin isoforms, including
Cx43 [60,61]. Several lines of evidence indicate that disruption of the in-
teraction between Cx43 and ZO-1 results in increased gap junction size.
For instance, fusion of a green ﬂuorescent protein (GFP) tag to the
carboxyl terminus of Cx43 results in increased gap junction size due
to masking of the carboxyl terminal amino acids of Cx43 that comprise
the ZO-1 binding site [62,63]. A similar effect on gap junction size is
observed when the Cx43–ZO-1 interaction is disrupted using a peptide
inhibitor [63]. The notion that ZO-1 regulates the size of gap junctions is
supported by studies demonstrating that mice expressing Cx43 with a
truncated carboxyl-terminal domain, unable to interact with ZO-1,
form enlarged gap junctions at cardiac intercalated disks [64]. A recent
study by Rhett et al. indicates that ZO-1 interacts with Cx43 in a region
around gap junction plaques termed the perinexus, and limits the rate
at which undocked Cx43 connexons incorporate into gap junction
plaques [65].
4. Gap junction endocytosis
In contrast to many integral membrane proteins, connexins have
high turnover rates in most tissue types, with half-lifes of 1.5–5 h
[66,67]. The turnover kinetics of connexins in various tissue types
and cell lines in comparison with other integral membrane proteins
was recently reviewed by Hervé et al. [14]. The observation that con-
nexins have a high turnover rate implies that modulation of the con-
nexin degradation rate might be an important mechanism for
controlling the level of gap junctional intercellular communication
under physiological and pathopysiological conditions, as discussed
in previous reviews [13–15,68–70]. There is growing evidence that
the connexin degradation rate can be modulated both at the level of
gap junction endocytosis as well as at the level of post-endocytic sort-
ing of connexins to lysosomes. Gap junctions are highly dynamic
structures. Under normal physiological conditions, connexons are
continually added to the edges of existing gap junctions and removed
from the center of the gap junction by endocytosis [33,71]. Under
some conditions, entire gap junction plaques may be internalized
[72]. Electron microscopy studies suggest that during endocytosis of
gap junctions, the two apposed membranes of the junction are inter-
nalized into one of the adjacent cells, forming a double-membranevacuole called an annular gap junction or connexosome [15,72–83].
Thismodel for gap junction endocytosis has been supported by studies in-
volving live imaging of GFP-tagged Cx43 and Cx32 [74,84–86], as well as
by correlative ﬂuorescence and electronmicroscopy of Cx43 containing a
tetracysteine tag [71]. In addition to the endocytosis of large gap junction
portions, multiple small domains of the plaque can be internalized [87].
Clathrin is recruited to gap junctions during endocytosis and is re-
quired for gap junction internalization [76,79,80,88,89]. Clathrin is dis-
tributed in distinct patches rather than coating the entire surface of
the gap junction plaque [80]. Recruitment of clathrin to gap junctions
during endocytosis has been suggested to be mediated by the cla-
thrin-adaptors AP-2 and Disabled-2 (Dab2) [80]. Several studies also
indicate that gap junction endocytosis involves the GTPase dynamin
[80,88,90]. Cx43 has also been found to interact with the rab GAP-like
protein CIP85 (Cx43-interacting protein of 85-kDa) [91]. CIP85 coloca-
lizes with Cx43 gap junctions at the plasma membrane and is involved
in regulating the rate of lysosomal degradation of Cx43 [91]. By electron
microscopy, internalized gap junctions are found to be coatedwith actin
ﬁlaments [76]. Studies by Falk and colleagues indicate that endocytosis
of gap junctions is dependent on intact actin ﬁlaments and on the
unconventional, retrograde actin motor myosin-VI [80].
As described above, ZO-1 regulates the rate of aggregation of
undocked Cx43 connexons into gap junction plaques, but may also
play a role in gap junction internalization. For instance, signiﬁcant in-
crease in the association between Cx43 and ZO-1 has been reported
during remodeling of myocyte intercellular contacts, raising the pos-
sibility that ZO-1 might be involved in gap junction endocytosis and
degradation during cardiac development and disease [92,93]. In-
creased association is also observed between Cx43 and ZO-1 in Sertoli
cells under conditions where gap junction endocytosis is induced by
the non-genotoxic carcinogen lindane (γ-hexachlorocyclohexane)
[94]. ZO-1 localizes on both sides of the gap junction plaques in
untreated cells, but appears to be mainly localized to one side during
endocytosis of the gap junctions in response to lindane treatment
[95]. The lindane-induced endocytosis of Cx43 gap junctions is de-
pendent on c-Src, and dissociation of ZO-1 from gap junctions ap-
pears to occur at the side of the plaque where c-Src is recruited [95].
Intercellular communication via Cx43 gap junctions is rapidly dis-
rupted after stimulation of certain G protein-coupled receptors
(GPCR) [96–98]. Studies by Moolenaar and co-workers indicate that
loss of phosphatidylinositol 4,5-bisphosphate (PtdIns[4,5]P2) at the
plasma membrane is necessary and sufﬁcient for the inhibition of
Cx43 gap junction intercellular communication in response to GPCR
stimulation [99]. Moreover, ZO-1 was found to bind to phospholipase
Cβ3 (PLC β3) and to be required for the GPCR-induced inhibition of
Cx43 gap junction channels, possibly by organizing Cx43 and PLC β3
into a complex that regulates the local levels of PtdIns(4,5)P2. In sub-
sequent studies, Baker et al. found that activation of GPCR by throm-
bin and endothelin-1 results in rapid internalization of Cx43 gap
junctions, in a process involving clathrin and ZO-1 [100].
Majoul and colleagues have found that drebrin (developmentally
regulated brain protein) has an important role in stabilizing Cx43 gap
junctions at the plasma membrane [101]. Drebrin is an actin-binding
protein that is involved in morphogenesis, patterning andmaintenance
of dendritic spines in neurons [102]. Drebrin binds to the C-terminal tail
of Cx43 and colocalizes with Cx43 at gap junction plaques. Depletion of
drebrin by siRNA results in destabilization of gap junctions and reloca-
lization of Cx43 to intracellular vesicles, which is associated with im-
paired intercellular communication via gap junctions [101]. Possibly,
drebrin may stabilize Cx43 gap junctions by acting as a link between
Cx43 and the actin cytoskeleton [101].
5. Post-endocytic sorting of connexins
Following internalization of gap junctions, connexins are degraded
in lysosomes [10,36,103–105]. There is increasing evidence that
Connexosome Recycling endosome? 
Early endosome 
Late endosome Lysosome 
Gap junction Hemichannels 
Endoplasmic reticulum 
Trans-Golgi network
Golgi apparatus 
Exocytic vesicles 
Cx43 
Connexon 
Hrs 
Tsg101 
Ubiquitinated connexon 
Nedd4 
Gap junction 
Connexosome 
Autophagosome 
1 2 3 
Eps15 
Proteasome 
4 5 
Endosome 
Fig. 1. Pathways for lysosomal delivery of Cx43. Cx43 is co-translationally inserted into the endoplasmic reticulum and transported via the Golgi apparatus and the trans-Golgi net-
work to the plasma membrane. A sub-population of newly synthesized Cx43 in the endoplasmic reticulum undergoes ERAD. Oligomerization of Cx43 into connexons occurs after
the protein has left the endoplasmic reticulum. Newly synthesized connexons are continually added to the edges of existing gap junctions and dock with connexons in neighboring
cells to form gap junction intercellular channels. During endocytosis of a gap junction, both membranes of the junction are internalized into one of the adjacent cells, to form a
connexosome. The ﬁgure depicts ﬁve possible pathways for delivery of Cx43 to lysosomes: 1) Fusion between connexosomes and lysosomes, 2) sequestration of connexosomes
by autophagosomes and subsequent fusion between the autophagosomes and lysosome, 3) transformation of the connexosome into a Cx43-enriched, multivesicular endosome
with a single limiting membrane and subsequent trafﬁcking of Cx43 to early and late endosomes prior to degradation of Cx43 in lysosomes, 4) endocytosis of connexons at the
plasma membrane not assembled in gap junctions, and 5) delivery of Cx43 to the endo-lysosomal system directly from the secretory pathway. Note that although depicted in
the ﬁgure, it is currently unknown whether early and late endosomes are involved in the pathways 4 and 5. The molecular mechanisms involved in the separation of the gap
junction double membrane in pathway 3 are currently unknown. Ubiquitination of Cx43 is mediated by the E3 ubiquitin ligase Nedd4. Ubiquitination of Cx43 has been shown
to be involved in pathway 3, and has been suggested to regulate internalization of Cx43 gap junctions as well as sorting of Cx43 from early endosomes to lysosomes. Eps15
binds to ubiquitinated Cx43 at the plasma membrane and participates in gap junction endocytosis. Ubiquitinated Cx43 is thought to be recognized and retained at the limiting
membrane of the early endosome by the ubiquitin-binding proteins Hrs and Tsg101. In addition to a ubiquitin-dependent pathway for Cx43 endocytosis, Cx43 may also follow
a ubiquitin-independent pathway, in which the YXXϕ motif in the Cx43 C-terminal tail has a key role. It is currently unknown if Cx43 ubiquitination is involved in pathway 1,
2, 4 or 5.
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their ﬁnal destination in lysosomes (Fig. 1). Several studies suggest
that connexosomes are able to directly fuse with lysosomes [89,105–
108]. Cx43may also be delivered to lysosomes directly from early secre-
tory compartments [105]. In addition, connexons at the plasma
membrane not assembled in gap junctions can be endocytosed and
degraded in lysosomes [109]. VanSlyke and Musil have shown that
cytosolic stress reduces degradation of Cx43 pools not assembled in
gap junctions [109]. Cytosolic stress did not affect Cx43 endocytosis,
but appeared to counteract the post-endocytic trafﬁcking of Cx43 to
lysosomes. Under these conditions, Cx43was able to recycle to the plas-
ma membrane and assemble into functional gap junctions. The ﬁnding
that degradation of Cx43 is reduced by cytosolic stress is likely to have
signiﬁcant physiological relevance. There is also evidence suggesting
that Cx43 may undergo recycling in unstressed cells. For instance, a
recent study by Boassa et al. indicates that Cx43 undergoes recycling
to the plasma membrane upon mitotic exit, which is associated with
reestablishment of gap junctions [110]. Moreover, Gilleron et al. have
found that Cx43 partly colocalizes with Rab11, a small GTPase involved
in the recycling pathway [90].
Importantly, recent studies indicate that connexins can be degraded
by autophagy. Berthoud and colleagues found that starvation inducesloss of Cx43 gap junctions and increased degradation of Cx43 in NRK
(normal rat kidney) cells [111]. Starvation had similar effects on Cx50
transfected into HeLa cells. Both Cx43 and Cx50 were found to coloca-
lize with autophagosomal markers in starved cells. As determined by
electron microscopy, starved mouse embryonic ﬁbroblasts endoge-
nously expressing Cx43 were found to contain internalized gap junc-
tions enclosed by double-membrane structures resembling
autophagosomes. Autophagy was also found to be involved in degrada-
tion of a cataract-associated mutant, Cx50-P88S, which accumulates in
the cytoplasm. A recent study byHesketh et al. indicates that autophagy
may play an important role in degradation of Cx43 in cardiomyocytes
[112]. As determined by electron microscopy, internalized gap junc-
tions in the failing canine ventricular myocardium were found to be
sequestered bymultilamellarmembrane structureswith characteristics
of autophagosomes.
Several lines of evidence indicate that Cx43 can be trafﬁcked to
early and late endosomes prior to its degradation in lysosomes. For
instance, Cx43 has been shown to co-localize with the early endo-
some markers EEA1 (early endosomal autoantigen 1) or Rab5 in
response to exposure to tumor-promoting chemicals, such as TPA
and lindane [77,113,114]. Moreover, Cx43 has been reported to co-
localize with EEA1 in mitotic cells [110]. Trafﬁcking of Cx43 to early
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instance, Segretain et al. have found that Cx43 is sequestrated in
early endosomes during Leydig cell tumor progression [115]. Endoso-
mal Cx43 sequestration was found to be an early event in Leydig cell
tumorigenesis and was associated with uncontrolled Leydig cell pro-
liferation in situ.
After entering the early endosome, endocytosed proteins can be
trafﬁcked further downstream the degradation pathway to the lyso-
some, undergo recycling to the plasma membrane, or be transported
to the trans-Golgi network [116]. Early endosomes have important
roles in regulating the levels of integral membrane proteins at the
plasma membrane, and participate in a range of processes, including
cell signaling, cytokinesis, polarity and migration. There is also grow-
ing evidence that early endosomes, in addition to being involved in
sorting of endocytosed proteins, function in signal propagation by
facilitating the recruitment of signaling molecules and integration of
signaling cascades at their surface [117]. Endocytosed proteins des-
tined for lysosomal degradation are transported into intraluminal
vesicles in early endosomes that bud from the limiting membrane
of the endosome [118]. As determined by immuno-electron micros-
copy, Cx43 localizes both at the limiting membrane of the early endo-
some, as well as in its intraluminal vesicles [77,113]. The observation
that Cx43 is transported to early endosomes following endocytosis of
Cx43 gap junctions raises the question of how Cx43 is trafﬁcked from
connexosomes, which are double-membrane structures, to early
endosomes, which consist of a single limiting membrane. Based on
immuno-electron microscopy studies, we have proposed that internal-
ized gap junctions can undergo a maturation process from double-
membrane vacuoles tomultivesicular, single-membrane vacuoles in re-
sponse to protein kinase C (PKC) activation [77,113,119]. This process is
associatedwith loss of the detergent resistance of Cx43 [119]. The trans-
formation of the double-membrane structure of the connexosome is
accompanied by trafﬁcking of Cx43 to early endosomes, possibly by
fusion between connexosomes and early endosomes [77,113]. A
scenario in which the gap junction double membrane is transformed
into two single membranes during or after its internalization implies
that the gap junction channels undock during or shortly after internali-
zation. Thus, in this model for gap junction endocytosis, most Cx43
localized in early endosomes is expected to exist as undocked connexons
[113]. The precise molecular mechanisms involved in the separation of
the gap junction doublemembrane in response to PKC activation remains
to be determined. Possibly, the PKC-induced phosphorylation of Cx43
might cause a conformational shift of the gap junction channel that trig-
gers undocking of the connexons.
Ubiquitination of integral membrane proteins has a key role in de-
termining their fate at early endosomes. As described below, recent
studies suggest that ubiquitination of Cx43 may be important in mod-
ulating both gap junction endocytosis, as well as in the sorting of
Cx43 at early endosomes.
6. Regulation of Cx43 ubiquitination
Increasing evidence indicates that connexin turnover is regulated by
a complex interplay between connexin phosphorylation and ubiquiti-
nation. Many connexin isoforms, including Cx43, are phosphoproteins
[120]. Among the protein kinases involved in regulating Cx43 phos-
phorylation are mitogen-activated protein kinase (MAPK), PKC, protein
kinase A, casein kinase 1, Src and cdc2 [120]. Cx43 is mainly phosphor-
ylated on serines, but may also be phosphorylated on tyrosines and
threonines. Phosphorylation of Cx43 is thought to occur exclusively in
its C-terminal tail. Other connexin isoforms, for instance Cx36 and
Cx56, have been shown to also be phosphorylated within their cyto-
plasmic loop [120]. Phosphorylation of connexins can regulate gap junc-
tions through a variety of mechanisms, for instance by affecting
connexin synthesis and trafﬁcking, assembly of connexons into gap
junctions or gating of gap junction channels [121]. There is alsosubstantial evidence that phosphorylation of Cx43 is important in regu-
lating gap junction internalization and degradation, as previously
reviewed by Laird [68]. Studies carried out the recent years suggesting
that Cx43 phosphorylation is tightly linked to Cx43 ubiquitination,
might have important implications for our understanding of how endo-
cytosis and degradation of connexins are regulated.
Ubiquitin is a globular protein consisting of 76 amino acids that is
able to covalently conjugate to other proteins [122]. The best-known
function of ubiquitination is to regulate protein degradation, but has
also important roles in regulating the activity or localization of proteins.
Ubiquitin is involved in a variety of cellular processes, including endo-
cytosis and post-endocytic trafﬁcking of integral membrane proteins.
Ubiquitin is covalently conjugated to proteins by forming a bond be-
tween the carboxy-terminal glycine of ubiquitin and the ε-NH2 group
of a lysine residue in the substrate protein. Alternatively, ubiquitin can
be conjugated to the α-NH2 group of the N-terminal amino acid of the
substrate [123,124]. In 1995, Laing and Beyer provided the ﬁrst evi-
dence that ubiquitin is involved in degradation of Cx43 [103,125]. By
using CHO (Chinese hamster ovary)-ts20 cells,which express a thermo-
labile E1 ubiquitin-activating enzyme, the Cx43 protein level was found
to increase under conditions where the ubiquitin-activating enzyme
was defective [125]. The increased levels of Cx43 expression observed
under these conditions was accompanied by enlarged Cx43 gap junc-
tions at the plasmamembrane as well as more diffuse Cx43 localization
in the cytoplasm. The authors also demonstrated that Cx43 can be con-
jugated to ubiquitin [103,125]. Subsequent studies by Ruts and Hülser
indicated that ubiquitin is localized at gap junction plaques, as deter-
mined by immuno-gold electron microscopy [126].
Ubiquitination of Cx43 has been found to be regulated by epidermal
growth factor (EGF) [127]. In many cell types, EGF causes inhibition of
gap junction channel permeability by inducing MAPK-mediated phos-
phorylation of Cx43 [128,129]. Warn-Cramer et al. have demonstrated
that the serines at positions 255, 279 and 282, located in the carboxyl-
terminal tail of Cx43, act as major phosphorylation sites during
MAPK-induced inhibition of gap junctions [130,131]. In some cell
types, such as the rat liver epithelial cell line IAR20, EGF is not only
able to block Cx43 gap junction channel permeability, but also stimu-
lates gap junction endocytosis and Cx43 degradation [127]. The EGF-in-
duced endocytosis of Cx43 is accompanied by increased Cx43
ubiquitination [127]. There appears to be a close association between
EGF-induced Cx43 phosphorylation and ubiquitination. For instance,
both the phosphorylation and ubiquitination levels of Cx43 are in-
creased few minutes after EGF exposure, and correlate during endocy-
tosis and post-endocytic trafﬁcking of Cx43 [113,127]. Moreover, both
EGF-induced ubiquitination and endocytosis of Cx43 is counteracted
by inhibitors of MEK1 [127]. There is increasing evidence that the EGF
receptor regulates endocytosis and degradation of Cx43 in multiple tis-
sue types. For instance, activation of EGF receptor by heparin-binding
EGF (HB-EGF) causes increased endocytosis and degradation of Cx43
in mouse cardiomyocytes [132].
Ubiquitination of Cx43 is also induced by the tumor-promoting
phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) [104,113].
TPA is a potent PKC activator which induces inhibition of gap junction
channels in multiple cell types [133–137]. The TPA-induced phosphor-
ylation of Cx43 and inhibition of Cx43 gap junction channels involve
the MAPK pathway [138–140]. In addition to inducing inhibition of
gap junction channel permeability, TPA exposure also results in in-
creased endocytosis of Cx43 gap junctions and enhanced Cx43 degrada-
tion in many cell types [136,141–143]. TPA-induced endocytosis and
degradation of Cx43 correlate with increased Cx43 ubiquitination
[104,113]. PKC has a major role in the TPA-induced ubiquitination of
Cx43. The TPA-induced Cx43 ubiquitination, endocytosis and degrada-
tion are strongly counteracted by inhibitors of PKC and partly counter-
acted by inhibitors of MEK1 [104]. Based on studies using antibodies
that differentiate between mono- and polyubiquitinated proteins,
Cx43 has been suggested to be modiﬁed by multiple monoubiquitins
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[104,144]. In future studies it will be important to elucidate in further
detail the type of ubiquitin modiﬁcation Cx43 is subjected to, as well
as to determine the Cx43 ubiquitin conjugation sites, by using mass
spectrometry. It will also be interesting to elucidate whether ubiquiti-
nation of distinct sites on Cx43 may affect gap junctions differentially.
The E3 ubiquitin ligases specify timing and substrate selection of
the ubiquitination reaction and are key regulatory determinants in
the ubiquitination process. The E3 ubiquitin ligases can be classiﬁed
into three major families: (1) the HECT (homologous to E6-AP car-
boxy terminal) E3s; (2) the RING (really interesting new gene) E3s;
and (3) the U-box E3s. Members of the HECT family of E3 ubiquitin li-
gase family contain an approximately 350-residue region at their car-
boxyl termini, termed the HECT domain [145]. Within the HECT
domain is a strictly conserved cysteine residue that acts as a site for
thiol ester formation with ubiquitin transferred from an E2-conjugat-
ing enzyme. This cysteine residue is essential for substrate ubiquitina-
tion. In contrast to the RING and U-box E3 ubiquitin ligases, HECT E3s
participate directly in catalyzing ubiquitination by forming a bond
with ubiquitin prior to the transfer of ubiquitin to the substrate pro-
tein. Another feature shared by many HECT E3s is the WW domain,
a short motif that can bind phosphoserine and phosphothreonine or
PY (XPPXY, where P is proline, X is any amino acid and Y is tyrosine)
motifs in the target protein and thereby mediate substrate recogni-
tion [146]. The prototype member of the HECT E3 ubiquitin ligase
family is Nedd4 (neural precursor cell expressed, developmentally
downregulated 4). Nedd4 is ubiquitously expressed in human tissues
and catalyzes ubiquitination of both soluble and trans-membrane
proteins, including various channel proteins such as ENaC (amilor-
ide-sensitive epithelial sodium channel) [147–149]. Leykauf et al.
have demonstrated that Nedd4 binds to the C-terminal tail of Cx43
[150]. The C-terminal tail of Cx43 harbors a proline-rich region corre-
sponding to the consensus of a PY motif, which is known to act as a
binding site for proteins containing WW domains, including the
Nedd4/Nedd4-like family of E3 ubiquitin ligases [151]. The rat
Nedd4 protein contains three WW domains, all of which are able to
bind to rat Cx43 [150]. Phosphorylation of Cx43 is not necessary for
Nedd4 binding. However, treating cells with EGF causes a signiﬁcant
increase in the binding of the WW3 domain to phosphorylated
Cx43, suggesting that phosphorylation of Cx43 might modulate the
binding of Nedd4 [150]. Depletion of Nedd4 by small interfering
RNA (siRNA) has been shown to result in accumulation of Cx43 gap
junctions at the plasma membrane [150]. Girão et al. have found
that mutation of the Cx43 PY motif reduces its interaction with
Nedd4, which is associated with reduced Cx43 ubiquitination [144].
The authors suggested that Nedd4 directly catalyzes ubiquitination
of Cx43 by interacting with its PY motif.
The PYmotif of Cx43 is overlapped by a tyrosine-based sorting sig-
nal conforming to the consensus YXXϕ (where Y is tyrosine, X is any
amino acid and ϕ is an amino acid with a bulky hydrophobic side
chain) [151]. This motif is found in the cytosolic domains of multiple
plasma membrane proteins [152]. The motif has an important role in
mediating protein internalization from the plasma membrane and in
targeting proteins to lysosomes [153,154]. For instance, the YXXϕ sig-
nal can interact with AP-2, an adaptor protein found in clathrin coats
at the plasma membrane [155,156]. Both the PY and the YXXϕmotifs
are important in regulating the level of Cx43 gap junctions at the plas-
ma membrane, possibly by controlling Cx43 endocytosis [151].
Whether connexins other than Cx43 undergo ubiquitination dur-
ing endocytosis, and what role Nedd4 might play in these processes
is currently unknown. Interestingly, Cx26 binds to OCP1 (Organ of
Corti protein 1), a protein that is a subunit of an SCF (Skp1/Cul1/F-
box complex) E3 ubiquitin ligase [157,158]. OCP1 is abundantly
expressed in the Organ of Corti [157–159]. Given that Cx26 is one of
the major gap junction proteins in the epithelial support complex of
the Organ of Corti, these ﬁndings raise the possibility that OCP1could be involved in regulating ubiquitination of Cx26 in this organ
[157,158].
7. Role of ubiquitin in endocytosis and post-endocytic sorting of
Cx43
Cx43 is thought to undergo ubiquitination at the plasma mem-
brane [127]. This notion is supported by the observation that ubiqui-
tin is recruited to Cx43 gap junction plaques in response to TPA
treatment, as determined by confocal microscopy [113], and by the
observation that Nedd4 partly colocalizes with Cx43 gap junctions
at the plasma membrane [150]. Studies by Girão et al. indicate that
ubiquitination of Cx43 is involved in regulating gap junction endocy-
tosis, and have identiﬁed Eps15 as a Cx43 binding partner. Eps15 con-
tains a clathrin-binding domain, as well as ubiquitin-interacting
motifs that bind directly to ubiquitinated proteins [160]. Eps15 is
thought to function as an adaptor that links ubiquitinated plasma
membrane proteins to clathrin-coated pits at the plasma membrane,
and may also be involved in mediating clathrin-independent endocy-
tosis of ubiquitinated proteins [161]. The binding between Eps15 and
Cx43 requires an intact ubiquitin-interacting motif in Eps15 [144].
The interaction between Eps15 and Cx43 is thought to require Cx43
ubiquitination, since depletion of Nedd4 by siRNA counteracts the in-
teraction between Eps15 and Cx43 [144]. The binding between Eps15
and Cx43 is also reduced when the PY motif of Cx43 is mutated. In a
recent study by Catarino et al., fusion of a ubiquitin moiety to the
Cx43 carboxyl-terminal tail to mimic Cx43 ubiquitination was found
to increase the association between Cx43 and Eps15 [162]. Fusion of
ubiquitin to Cx43 resulted in increased endocytosis and degradation
of Cx43, in a process that was independent of the YXXϕ motif [162].
Depletion of Eps15 by siRNA results in enlarged gap junctions, sug-
gesting that Eps15 might be involved in mediating endocytosis of
Cx43, possibly by acting as a link between ubiquitinated Cx43 and
components of the endocytic machinery [144]. However, depletion
of Eps15 has no effect on the Cx43 protein level [144].
In addition to being involved in internalization of Cx43 at the plas-
ma membrane, ubiquitin may also be involved in the post-endocytic
sorting of Cx43 to lysosomes. The formation of intraluminal vesicles
in early endosomes is preceded by accumulation of endocytosed pro-
teins on ﬂat clathrin-coated membrane areas on the endosomal limit-
ing membrane [118]. Ubiquitination of endocytosed proteins is a
signal for their accumulation on such ﬂat clathrin coats, and hence
for their subsequent degradation in lysosomes. Hrs (hepatocyte
growth factor-regulated tyrosine kinase substrate) contains a cla-
thrin-binding domain and localizes in clathrin-coated domains on
early endosomes [163]. Hrs binds to ubiquitinated proteins via a ubi-
quitin-interacting motif, and sorts ubiquitinated membrane proteins
to the clathrin-coated domains and counteract their recycling to the
cell surface [163]. Hrs also has a key role in the formation of intralu-
menal vesicles in early endosomes by interacting with Tsg101
(tumor-susceptibility gene product 101), a subunit of the endosomal
sorting complex required for transport (ESCRT) I [164]. ESCRT I is a
protein complex which, together with ESCRT II and III, regulate pro-
tein sorting and formation of intraluminal vesicles in early endo-
somes. Both Hrs and Tsg101 have been shown to be involved in
regulating the trafﬁcking of Cx43 from early endosomes to lysosomes
in response to TPA treatment [113]. When Hrs and Tsg101 were si-
multaneously depleted by siRNA, a sub-pool of ubiquitinated Cx43
was found to remain localized in early endosomes, even after pro-
longed TPA treatment [113].
Auth et al. have demonstrated that Tsg101 interacts directly with
the Cx43 carboxyl-terminal tail [165]. The interaction between Cx43
and Tsg101 was increased in response to TPA treatment. Tsg101
was also shown to interact with the carboxyl-terminal regions of
Cx30.2, Cx36 and Cx45 [165]. Tsg101 and other components of the
ESCRT machinery have important roles in the regulation of cell
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endocytic sorting of Cx43 is regulated by the ESCRT complex may
have important implications for understanding the mechanisms
underlying the dysregulation of Cx43 trafﬁcking during cancer devel-
opment and other diseases.
Recent studies indicate that ubiquitination of integral plasma
membrane proteins not only is involved in mediating their trafﬁcking
from early endosomes to lysosomes, but may also have important
roles in targeting proteins for degradation by autophagy [167]. An
important subject for future studies will be to elucidate whether
ubiquitination of Cx43 is involved in targeting connexosomes for
degradation by autophagy.
8. Role of the proteasome in endocytosis of Cx43 gap junctions
In addition to playing a key role during ERAD, the proteasome is
also involved in the endocytosis of plasma membrane proteins
[152]. Degradation of Cx43 gap junctions is counteracted by proteaso-
mal inhibitors [16,103,105,125]. The proteasome appears to play an
indirect role in degradation of Cx43 gap junctions, by affecting Cx43
internalization [13,103,105,109]. The precise mechanisms by which
proteasomal inhibitors interfere with Cx43 endocytosis are unclear.
However, since treatment of cells with proteasomal inhibitors causes
accumulation of polyubiquitinated proteins and, as a consequence,
depletion of the pool of unconjugated ubiquitin, proteasomal inhibi-
tors might counteract Cx43 endocytosis by reducing Cx43 ubiquitina-
tion [104,113]. Proteasomal inhibitorsmay also counteract endocytosis
of Cx43 by affecting the stability of various Cx43-interacting proteins.
For instance, proteasomal inhibitors have been shown to reduce the
interaction between Cx43 and ZO-1, which is associated with the
formation of enlarged gap junctions [168].
9. Concluding remarks and future perspectives
It has become clear that connexins may follow multiple pathways
en route to their degradation in lysosomes. Moreover, the various
pathways appear to be differentially regulated in response to physio-
logical and pathophysiological stimuli. There is growing evidence that
endosomes may have important roles in controlling the level of con-
nexins at the plasma membrane. This notion is supported by recent
studies indicating that connexins are able to undergo recycling to
the plasma membrane after endocytosis. In future studies it will be
important to obtain a better molecular understanding of how the bal-
ance between degradation and recycling of connexins is regulated,
and how these processes are affected by various types of cytosolic
stress. Post-translational modiﬁcations of connexins are likely to
have a key role in the regulation of gap junction endocytosis and lyso-
somal sorting of connexins. Research carried out the recent years sug-
gests that endocytosis and degradation of Cx43 are regulated by a
complex interplay between Cx43 phosphorylation and ubiquitina-
tion. An important subject for future studies will be to obtain a clearer
understanding of how ubiquitination of Cx43 and other connexin iso-
forms is regulated under normal physiological conditions, and wheth-
er dysregulation of these processes contributes to loss of functional
gap junctions under various disease states. There is increasing evi-
dence that aberrant regulation of connexin endocytosis and post-
endocytic trafﬁcking may be involved in various pathological condi-
tions, including cardiac diseases and cancer. Understanding the
molecular basis underlying these processes may have important
therapeutic implications.
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